Home
Jubilant Pharmova Ltd PE Ratio

Jubilant Pharmova Ltd
NSE: JUBLPHARMA
PE
Key Highlights
- The P/E Ratio of Jubilant Pharmova Ltd is 45.9 as of 03 Apr 9.00 AM .
- The P/E Ratio of Jubilant Pharmova Ltd changed from 4.4 on March 2020 to 116.5 on March 2024 . This represents a CAGR of 92.56% over 5 years.
- The Latest Trading Price of Jubilant Pharmova Ltd is ₹ 971.65 as of 03 Apr 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.
Historical P/E Ratio of Jubilant Pharmova Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Jubilant Pharmova Ltd
Company Fundamentals for Jubilant Pharmova Ltd

Jubilant Pharmova Ltd
NSE: JUBLPHARMA
Share Price
Market Price of Jubilant Pharmova Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
03 Apr 2025 | 971.65 |
02 Apr 2025 | 909.6 |
01 Apr 2025 | 914.4 |
28 Mar 2025 | 892.7 |
27 Mar 2025 | 891.75 |
26 Mar 2025 | 859.55 |
25 Mar 2025 | 870.55 |
24 Mar 2025 | 895.7 |
21 Mar 2025 | 902.55 |
20 Mar 2025 | 898.55 |
SWOT Analysis Of Jubilant Pharmova Ltd
BlinkX Score for Jubilant Pharmova Ltd
Asset Value vs Market Value of Jubilant Pharmova Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Jubilant Pharmova Ltd | 15478 | 45.92 |
Sun Pharmaceutical Industries Ltd | 424706 | 36.0 |
Divis Laboratories Ltd | 152946 | 74.0 |
Cipla Ltd | 120751 | 24.2 |
Torrent Pharmaceuticals Ltd | 109983 | 59.1 |
Mankind Pharma Ltd | 100168 | 49.1 |
Company | |
---|---|
Jubilant Pharmova Ltd | 15478 |
Sun Pharmaceutical Industries Ltd | 424706 |
Divis Laboratories Ltd | 152946 |
Cipla Ltd | 120751 |
Torrent Pharmaceuticals Ltd | 109983 |
Mankind Pharma Ltd | 100168 |
PE Ratio of Jubilant Pharmova Ltd Explained
₹15478
Market cap
₹627
Earnings
45.9X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Jubilant Pharmova Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Jubilant Pharmova Ltd
Historical Revenue, EBITDA and Net Profit of Jubilant Pharmova Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Jubilant Pharmova Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Jubilant Pharmova Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Jubilant Pharmova Ltd
About Jubilant Pharmova Ltd
- Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
- The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
- The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA. The contract research and development segment provides drug discovery and development services as well as clinical data software and service solutions.
Jubilant Pharmova Ltd News Hub
Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories
Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant Biosys (J
Read more
16 Aug 24
Volumes soar at Jubilant Pharmova Ltd counter
Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Metals & Ene
Read more
01 Aug 24
Volumes soar at Jubilant Pharmova Ltd counter
Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are among the othe
Read more
09 Sept 24
Jubilant Pharmova Ltd leads gainers in 'A' group
Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemicals Ltd are
Read more
09 Sept 24